Divalproex Sodium
FDA Label NDC 0904-7181

63 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Divalproex Sodium (NDC 0904-7181). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: life threatening adverse reactions, 1.1 mania, 1.2 epilepsy, 1.3 migraine, 1.4 important limitations, 2 dosage and administration, 2.1 mania, 2.2 epilepsy, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package/Label Display Panel

MAJOR®

NDC 0904-7181-61

Unit Dose

ONCE-DAILY DOSING

DIVALPROEX SODIUM

EXTENDED-RELEASE

TABLETS, USP

250 mg*

(Valproic Acid Activity)

PHARMACIST: DISPENSE WITH

MEDICATION GUIDE

Rx only

100 TABLETS

250mg Carton Label (5284ecb4 6f0a 4388 8f78 A48e0c0123d6 01)

250mg Carton Label (5284ecb4 6f0a 4388 8f78 A48e0c0123d6 01)

MAJOR®

NDC 0904-7182-61

Unit Dose

Once-Daily Dosing

Divalproex Sodium

Extended-release

Tablets, USP

500 mg*

(Valproic Acid Activity)

Pharmacist: Dispense with Medication Guide

100 TABLETS (10 x 10)

Rx only

500mg Carton Label (5284ecb4 6f0a 4388 8f78 A48e0c0123d6 00)

500mg Carton Label (5284ecb4 6f0a 4388 8f78 A48e0c0123d6 00)

* Please review the disclaimer below.